A Business Review Of iBio Inc (AMEX: IBIO) And Growth Forecast

In the last trading session, 2.2 million shares of the iBio Inc (AMEX:IBIO) were traded, and its beta was 1.30. Most recently the company’s share price was $6.41, and it changed around $0.58 or 9.95% from the last close, which brings the market valuation of the company to $63.30M. IBIO currently trades at a discount to its 52-week high of $5.83, offering almost 9.05% off that amount. The share price’s 52-week low was $1.05, which indicates that the current value has risen by an impressive 83.62% since then.

iBio Inc stock received a consensus recommendation rating of Buy, based on a mean score of 1.00. If we narrow it down even further, the data shows that 0 out of 2 analysts rate the stock as a Sell; another 0 rate it as Overweight. Among the rest, 0 recommended IBIO as a Hold, whereas 2 deemed it a Buy, and 0 rated it as Underweight. iBio Inc is expected to report earnings per share of -0.32 for the current quarter.

iBio Inc (AMEX:IBIO) trade information

Instantly IBIO has showed a green trend with a performance of 9.95% at the end of last trading. The performance over the last five days has remained in the green territory. The rise to weekly highs of 6.89 on recent trading dayincreased the stock’s daily price by 6.97%. The company’s shares are currently up 161.63% year-to-date, but still up 86.34% over the last five days. On the other hand, iBio Inc (AMEX:IBIO) is 115.82% up in the 30-day period.

The consensus price target as assigned by Wall Street analysts is $3.6, which translates to bulls needing to decrease their stock price by -78.06% from its current value. Analyst projections state that IBIO is forecast to be at a low of $3.6 and a high of $3.6.

iBio Inc (IBIO) estimates and forecasts

The year-over-year growth rate is expected to be 77.78%, up from the previous year.

Consensus estimates provided by 2 financial analysts predict the company will bring in an average of 100k in revenue for the current quarter. 2 analysts expect iBio Inc to make 100k in revenue for the current ending quarter. Forecasts for the next quarter put sales growth at -42.86%.

Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 57.55%. iBio Inc earnings are expected to increase by 60.55% in 2025, but the outlook is positive 45.01% per year for the next five years.